Partial duplication of the MLL oncogene in patients with aggressive acute myeloid leukemia

Haematologica

Volumn 89, Issue 4, 2004, Pages 403-407

  Sambani, Constantina ^a   La Starza, Roberta ^b   Roumier, Christophe ^c   Crescenzi, Barbara ^b   Stavropoulou, Chryssa ^a   Katsarou, Olga ^d   Karafoulidou, Anastasia ^d   Dhalle, Jean Hugues ^c   Lai, Jean Luc ^c   Preudhomme, Claude ^c   Martelli, Massimo Fabrizio ^b   Mecucci, Cristina ^b,e  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF PERUGIA   (Italy)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d LAIKO GENERAL HOSPITAL   (Greece)

^e POLICLINICO MONTELUCE   (Italy)

Author keywords

3 MLL; AML; MLL gene; T(11; 16)(q23; p13.3); T(9; 11)(p22; q23)

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; CHIMERA; CHROMOSOME; CHROMOSOME 1; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DUPLICATION; GENE TRANSLOCATION; GENETIC RECOMBINATION; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; KARYOTYPE; MALE; MITOSIS; MLL ONCOGENE; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; ONCOGENE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 9; CYTOGENETIC ANALYSIS; FEMALE; GENE DUPLICATION; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; TRANSLOCATION, GENETIC;

EID: 2942724104     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rowley JD. The role of chromosome translocations in leukemogenesis. Semin Hematol 1999;36:59-72.
2. Pui CH, Relling M. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol 2000;109:13-23.
3. Swansbury GJ, Slater R, Bain BJ, Moorman AV, Secker-Walker LM. Hematological malignancies with t(9;11)(p21-22;q23). A laboratory and clinical study of 125 cases. European 11q23 Workshop participants. Leukemia 1998;12:792-800.
4. Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, et al. All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 1997;90:535-41.
5. Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RSK, et al. The translocation t(8; 16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996;14:33-41.
6. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, et al. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 1997;94:8732-7.
7. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, et al. Succesful use of the same slide for consecutive fluorescence in situ hybridization (FISH) experiments. Genes Chromosom Cancer 1996;16:261-4
8. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001;20:5695-707.
9. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994;83:2780-6.
10. Slater DJ, Hilgenfeld E, Rappaport EF, Shah N, Meek RG, Williams WR, et al. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site. Oncogene 2002;21:4706-14.
11. Angioni A, La Starza R, Mecucci C, Sprovieri T, Matteucci C, De Rossi G, et al. Interstitial insertion of AF10 into the ALL1 gene in a case of infant acute lymphoblastic leukemia. Cancer Genet Cytogenet 1998;107:107-10.
12. Mitelman Database of Chromosome Aberrations in Cancer. Mitelman F, Johansson B, Mertens F, Editors. 2000. http://cgap.nci.nih.gov/Chromosomes/Mit elman
13. Satake N, Ishida Y, Otoh Y, Hinohara S, Kobayashi H, Sakashita A, et al. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation. Genes Chromosomes Cancer 1997;20:60-3.
14. Johansson B, Moorman AV, Secker-Walker LM on behalf of the European 11q23 Workshop participants. Derivative chromosomes of 11q23-translocations in hematologic malignancies. Leukemia 1998;12:828-33.
15. Minissi S, Degrassi F, Tanzarella C, Gustavino B. Direct and indirect non-disjunction in the origin of trisomy in cultured human lymphocytes. Mutagenesis 1999;14:557-62.
16. Giussani U, Facchinetti B, Cassina G, Zuffardi O. Mitotic recombination among acrocentric chromosomes' short arm. Ann Hum Genet 1996;60:91-7.
17. Kerim S, Rege-Cambrin G, Guerrasio A, Rosso C, Van den Berghe H. Molecular cytogenetic analysis discloses complex genetic imbalance in a t(11;21) myelodysplastic syndrome. Cancer Genet Cytogenet 1990;46:243-50.
18. Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers G-J, Van der Plas et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosom Cancer 1993;8:237-45.
19. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrózek K, Bloomfield CD, et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support etiologic role for MLL gain of function in myeloid melignancies. Blood 2004;103:229-35.
20. Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, et al. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosom Cancer 2002;33:60-72.